Korsana Biosciences KRSA
NASDAQ KRSA
$31.11 +0.13 (+0.42%)
At close: Nov 10, 2026 · 4:00 PM EST

Korsana Biosciences (KRSA) Other Operating Expenses (2020 - 2025)

Updated

Korsana Biosciences' Other Operating Expenses was $1.32 million in Q2 2025.

Analysis

Korsana Biosciences (KRSA) Other Operating Expenses (2020 - 2025) Analysis & Trends

For FY2023, Other Operating Expenses at Korsana Biosciences came in at $3.3 million.

  • In earlier years, Other Operating Expenses was -$881,000 in FY2021 and -$1.67 million in FY2020.
  • The Q2 2025 figure marks the highest quarterly Other Operating Expenses since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korsana Biosciences 1.42 Bn 802.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.32 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2021 -881,000.00
Sep 30, 2020 444,000.00
Mar 31, 2020 -2.11 Mn
API Access

Korsana Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=KRSA&period=max&api_key=YOUR_API_KEY